NOVAVAX INC Public Float
NOVAVAX INC (NVAX) had Public Float of $1.02 billion as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $1.02B.
- 2024-06-30: Entity Public Float $2.02B.
- 2023-06-30: Entity Public Float $699.00M.
- 2022-06-30: Entity Public Float $4.01B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.02B 10-K · filed 2026-02-26 |
| 2024-06-30 | $2.02B 10-K · filed 2025-02-27 |
| 2023-06-30 | $699.00M 10-K · filed 2024-02-28 |
| 2022-06-30 | $4.01B 10-K · filed 2023-02-28 |
| 2021-06-30 | $15.70B 10-K · filed 2022-03-01 |
| 2020-06-30 | $5.08B 10-K/A · filed 2021-04-30 |
| 2019-06-30 | $138.30M 10-K · filed 2020-03-11 |
| 2018-06-30 | $505.90M 10-K · filed 2019-03-18 |
| 2017-06-30 | $328.50M 10-K · filed 2018-03-14 |
| 2016-06-30 | $1.65B 10-K · filed 2017-02-27 |
| 2015-06-30 | $2.95B 10-K · filed 2016-02-29 |
| 2014-06-30 | $934.60M 10-K · filed 2015-02-27 |
| 2013-06-30 | $246.50M 10-K · filed 2014-03-12 |
| 2012-06-29 | $185.20M 10-K · filed 2013-03-12 |
| 2011-06-30 | $172.60M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |